• Je něco špatně v tomto záznamu ?

Deciphering the regulation of P2X4 receptor channel gating by ivermectin using Markov models

L. Mackay, H. Zemkova, SS. Stojilkovic, A. Sherman, A. Khadra,

. 2017 ; 13 (7) : e1005643. [pub] 20170714

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17030690

The P2X4 receptor (P2X4R) is a member of a family of purinergic channels activated by extracellular ATP through three orthosteric binding sites and allosterically regulated by ivermectin (IVM), a broad-spectrum antiparasitic agent. Treatment with IVM increases the efficacy of ATP to activate P2X4R, slows both receptor desensitization during sustained ATP application and receptor deactivation after ATP washout, and makes the receptor pore permeable to NMDG+, a large organic cation. Previously, we developed a Markov model based on the presence of one IVM binding site, which described some effects of IVM on rat P2X4R. Here we present two novel models, both with three IVM binding sites. The simpler one-layer model can reproduce many of the observed time series of evoked currents, but does not capture well the short time scales of activation, desensitization, and deactivation. A more complex two-layer model can reproduce the transient changes in desensitization observed upon IVM application, the significant increase in ATP-induced current amplitudes at low IVM concentrations, and the modest increase in the unitary conductance. In addition, the two-layer model suggests that this receptor can exist in a deeply inactivated state, not responsive to ATP, and that its desensitization rate can be altered by each of the three IVM binding sites. In summary, this study provides a detailed analysis of P2X4R kinetics and elucidates the orthosteric and allosteric mechanisms regulating its channel gating.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030690
003      
CZ-PrNML
005      
20171102111034.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pcbi.1005643 $2 doi
035    __
$a (PubMed)28708827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mackay, Laurent $u Department of Physiology, McGill University, Montreal, Québec, Canada.
245    10
$a Deciphering the regulation of P2X4 receptor channel gating by ivermectin using Markov models / $c L. Mackay, H. Zemkova, SS. Stojilkovic, A. Sherman, A. Khadra,
520    9_
$a The P2X4 receptor (P2X4R) is a member of a family of purinergic channels activated by extracellular ATP through three orthosteric binding sites and allosterically regulated by ivermectin (IVM), a broad-spectrum antiparasitic agent. Treatment with IVM increases the efficacy of ATP to activate P2X4R, slows both receptor desensitization during sustained ATP application and receptor deactivation after ATP washout, and makes the receptor pore permeable to NMDG+, a large organic cation. Previously, we developed a Markov model based on the presence of one IVM binding site, which described some effects of IVM on rat P2X4R. Here we present two novel models, both with three IVM binding sites. The simpler one-layer model can reproduce many of the observed time series of evoked currents, but does not capture well the short time scales of activation, desensitization, and deactivation. A more complex two-layer model can reproduce the transient changes in desensitization observed upon IVM application, the significant increase in ATP-induced current amplitudes at low IVM concentrations, and the modest increase in the unitary conductance. In addition, the two-layer model suggests that this receptor can exist in a deeply inactivated state, not responsive to ATP, and that its desensitization rate can be altered by each of the three IVM binding sites. In summary, this study provides a detailed analysis of P2X4R kinetics and elucidates the orthosteric and allosteric mechanisms regulating its channel gating.
650    _2
$a adenosintrifosfát $x metabolismus $7 D000255
650    _2
$a algoritmy $7 D000465
650    _2
$a vazebná místa $7 D001665
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a gating iontového kanálu $x účinky léků $x fyziologie $7 D015640
650    _2
$a ivermektin $x metabolismus $7 D007559
650    _2
$a Markovovy řetězce $7 D008390
650    _2
$a metoda terčíkového zámku $7 D018408
650    _2
$a purinergní receptory P2X4 $x účinky léků $x metabolismus $x fyziologie $7 D058848
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zemkova, Hana $u Department of Cellular and Molecular Neuroendocrinology, Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Stojilkovic, Stanko S $u Section on Cellular Signaling, Eunice Kennedy Shiver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
700    1_
$a Sherman, Arthur $u Laboratory of Biological Modeling, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
700    1_
$a Khadra, Anmar $u Department of Physiology, McGill University, Montreal, Québec, Canada.
773    0_
$w MED00008919 $t PLoS computational biology $x 1553-7358 $g Roč. 13, č. 7 (2017), s. e1005643
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28708827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171102111127 $b ABA008
999    __
$a ok $b bmc $g 1254283 $s 991717
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 13 $c 7 $d e1005643 $e 20170714 $i 1553-7358 $m PLoS computational biology $n PLoS Comput Biol $x MED00008919
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace